Prof. Sabry A El-Naggar, PhD - Tanta University -  Professor

Prof. Sabry A El-Naggar

PhD

Tanta University

Professor

Tanta, Ghrabia | Egypt

Main Specialties: Biology

Additional Specialties: Physiology

ORCID logohttps://orcid.org/0000-0002-3001-795X


Top Author

Prof. Sabry A El-Naggar, PhD - Tanta University -  Professor

Prof. Sabry A El-Naggar

PhD

Introduction

Sabry A. El-Naggar (PhD, 2007) is a Professor of Physiology at Tanta University, Egypt and was Post-doc at Hollings Cancer Center, Medical University of South Carolina, USA. Dr. El-Naggar is a member of the team of Center of Excellence in Cancer Research (CECR), Tanta University, Egypt and the Director of the Proteomic Unit in CECR, one of the founders of Egyptian Association for Cancer Research. Dr. El-Naggar obtained his PhD in 2007 in Physiology through a channel system between Tanta University, Egypt and the Medical University of South Carolina (MUSC), USA, From 2004 -2007. He was a Postdoctoral Fellow at the Medical University of South Carolina, USA from 2008 -2010. Dr El-Naggar won the State Incentive Award in 2011 in Biology Sciences from the Academy of Scientific Research and Technology, Egypt. El-Naggar h-index is 10 and published about 30 articles in peer-reviewed journals, with more that 650 international citations and attended more than 20 national and international workshops and conferences in Immunology and Physiology subjects. He supervised on Master and PhD students in Faculty of Science, Tanta University. He is a member of many Editorial Boards of peer-reviewed journals as well as ad hoc reviewer for several international journals. Dr. El-Naggar research focuses on understanding the cellular and molecular mechanisms underlying how cancer escape from host immunity, in particular the rules of the immunosuppressive cells including lymphoid and myeloid lineages as well as developing effective anticancer immunotherapy strategies. His research projects have been funded by National Institute of Health, USA, Science and Technology Development Fund (STDF), Egypt, USA National Academy of Sciences, Tanta University, Egypt, private foundation and industry. Recently, Dr El-Naggar joined the Center of Excellence in Cancer Research (CECR) as an active member in the research team and appointed as a Director of the Proteomic Unit in CECR

Primary Affiliation: Tanta University - Tanta, Ghrabia , Egypt

Specialties:

Additional Specialties:

Research Interests:


View Prof. Sabry A El-Naggar’s Resume / CV

Education

Sep 2004 - Feb 2007
Tanta University
Ph.D
Zoology Department

Experience

Mar 2012
Tanta University
Professor

Publications

13Publications

333Reads

3Profile Views

Cardioprotective effect of green tea extract and vitamin E on Cisplatin-induced cardiotoxicity in mice: Toxicological, histological and immunohistochemical studies.

Biomed Pharmacother 2019 May 6;113:108731. Epub 2019 Mar 6.

Zoology Department, Faculty of Science, Tanta University, Tanta, Egypt. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2019.108731DOI Listing
May 2019
10 Reads
2.023 Impact Factor

Evaluation of antibacterial and anticancer properties of poly(3-hydroxybutyrate) functionalized with different amino compounds.

Int J Biol Macromol 2019 Feb 25;122:793-805. Epub 2018 Oct 25.

Chemistry Department, Faculty of Science, Tanta University, Tanta 31527, Egypt.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01418130183216
Publisher Site
http://dx.doi.org/10.1016/j.ijbiomac.2018.10.164DOI Listing
February 2019
36 Reads
2.858 Impact Factor

Cyclophosphamide eradicates murine immunogenic tumor coding for a non-self-antigen and induces antitumor immunity.

Int J Immunopathol Pharmacol 2018 Jan-Dec;32:2058738418796591

5 Zoology Department, Faculty of Science, Cairo University, Giza, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2058738418796591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168726PMC
December 2018
46 Reads
2.507 Impact Factor

Higher Activities of Hepatic Versus Splenic CD8+ T Cells in Responses to Adoptive T Cell Therapy and Vaccination of B6 Mice with MHC Class-1 Binding Antigen.

Iran J Allergy Asthma Immunol 2017 Dec;16(6):537-553

Laboratory of Immunology and Molecular Biology, Zoology Department, Faculty of Science, Assiut University, Assiut, Egypt.

View Article

Download full-text PDF

Source
December 2017
11 Reads
1.013 Impact Factor

Growth, hydrolases and ultrastructure of Fusarium oxysporum as affected by phenolic rich extracts from several xerophytic plants.

Pestic Biochem Physiol 2017 Sep 19;141:57-64. Epub 2016 Nov 19.

Department of Biology, Faculty of Science, Aljouf University, Sakakah, Aljouf, Saudi Arabia; Zoology Department, Faculty of Science, Tanta University, Tanta 3111, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pestbp.2016.11.007DOI Listing
September 2017
41 Reads
2.014 Impact Factor

Efficacy of Rosmarinus officinalis leaves extract against cyclophosphamide-induced hepatotoxicity.

Pharm Biol 2016 Oct 1;54(10):2007-16. Epub 2016 Feb 1.

b Department of Zoology, Faculty of Science , Tanta University , Tanta , Egypt ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/13880209.2015.1137954DOI Listing
October 2016
32 Reads
1.337 Impact Factor

Ameliorative effect of propolis against cyclophosphamide-induced toxicity in mice.

Pharm Biol 2015 Feb 7;53(2):235-41. Epub 2014 Oct 7.

Department of Biology, College of Science, Aljouf Univesity , Sakakah , KSA .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/13880209.2014.914230DOI Listing
February 2015
28 Reads
1.337 Impact Factor

Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.

Cell Immunol 2010 5;261(2):134-43. Epub 2009 Dec 5.

Surgery Department and Hollings Cancer Center, Medical University of South Carolina, Charleston, 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2009.11.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821961PMC
March 2010
11 Reads
1.924 Impact Factor

Cyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cells.

J Immunol 2010 Feb 18;184(4):1737-47. Epub 2010 Jan 18.

Department of Surgery, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0902309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066076PMC
February 2010
9 Reads
4.922 Impact Factor

The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice.

Vaccine 2009 Jan 21;27(4):549-57. Epub 2008 Nov 21.

Department of Surgery, Medical University of South Carolina, Charleston, SC 29425, USA; Department of Zoology, Faculty of Science, Tanta University, Tanta, Egypt.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2008.11.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072892PMC
January 2009
15 Reads
3.624 Impact Factor

Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.

J Immunother 2007 Jan;30(1):40-53

Department of Surgery, Section of Surgical Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.cji.0000211311.28739.e3DOI Listing
January 2007
13 Reads
4.008 Impact Factor

The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu.

Vaccine 2006 Jun 2;24(24):5119-32. Epub 2006 May 2.

Department of Surgery, Section of Surgical Oncology, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://wwwnc.cdc.gov/eid/article/12/4/05-0599_article.htm
Publisher Site
http://dx.doi.org/10.1016/j.vaccine.2006.04.010DOI Listing
June 2006
47 Reads
3.624 Impact Factor